Non-invasive Vagal Nerve Stimulation as Novel Treatment to Improve Functional Outcomes in Veterans With Alcohol Use Disorder

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2029

Conditions
Alcohol Use Disorder
Interventions
DEVICE

Cervical transcutaneous vagus nerve stimulation (active comparator)

Active nVNS produces low-voltage electrical signal that generates sensations on the skin on upper anterior cervical area (overlying carotid artery) and that stimulates the vagus nerve.

DEVICE

Cervical transcutaneous vagus nerve stimulation (sham comparator)

Sham nVNS devices look identical to active devices and participants will undergo identical training for self-administration on upper anterior cervical area (overlying carotid artery). Sham devices do not stimulate the vagus nerve.

Trial Locations (1)

92161-0002

RECRUITING

VA San Diego Healthcare System, San Diego, CA, San Diego

All Listed Sponsors
lead

VA Office of Research and Development

FED